Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
IPO
Alerts
About
Alivus Life Sciences Ltd.
NSE: ALIVUS
|
BSE: 543322
|
ISIN: INE03Q201024
|
Industry: Pharmaceuticals
|
Slowing Down Stock
888.6000
11.90
(
1.36
%)
NSE
Jan 14, 2026
15:31 PM
Near 52W Low of ₹847.20
Volume:
38,697
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alivus Life Sciences Ltd.
16 Jul 2024
888.60
1.36%
Glenmark Life Sciences Ltd
Buy:
Alivus Life Sciences Ltd.
by
Hem Securities
Target: 987
Hem Securities
Alivus Life Sciences.. has an
average target
of 1248.50 from 2 brokers.
More from Alivus Life Sciences Ltd.
Recommended
Nifty 50 outlook: Hopes rise for 2026 after a volatile year
The Baseline |
15 Jan 2026, 01:13PM
The top five: Analysts pick their winners for Q3
The Baseline |
15 Jan 2026, 11:06AM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
|
27 Jul 2021